In addition, the identification of familial, AD-linked mutations in the genes for APP and presenilin (PSEN1 and PSEN2) associated with dysregulation of Aβ peptide production suggests that APP processing is at the heart of the disease process. Here, PSEN2 is linked to Alzheimer disease.